CryoText™
Wharton’s Jelly Allograft
CryoText™ is our most concentrated, non-coded Wharton’s jelly or human umbilical cord product that is rich in cytokines, growth factors, and scaffolding proteins. It is used as a replacement tissue that is intended to replace missing or damaged connective tissue.
WHARTON’S JELLY ALLOGRAFT
CryoText™ is regulated as a human cell, tissue or cellular tissue-based product (HCT/P) under 21 CFR Part 1271 and Section 361 of the Public Health Service Act. Regenative Labs’ products are ethically derived and do not contain any material obtained from an embryo or fetus. Regenative Labs birth tissue allografts are derived from healthy, consenting mothers after full-term, live, planned, Cesarean section (C-section) deliveries.
Documented Case Studies with Encouraging Results Include:
- Muscular Tears
- Intervertebral Disc Spinal Facet Joints
- Plantar Fasciitis Bone Spurs
- Rotator Cuff Tears
- Persistent Partial Tendon Tears
- Quadriceps and Patellar Tendon Tears
- Meniscus and Cartilage Tears
- Radicular and Sacroiliac Nerves and Pinched Nerves
- Large Joints Such As The Hip, Shoulder, Knee
Advantages of CryoText™
CryoText™ is used as replacement tissue that is inserted or implanted into the joint and other injured areas. CryoText™ does not use any material obtained directly from the embryo or fetus. CryoText™ has higher concentrations of peptides, hyaluronic acid and growth factors when compared to amniotic fluid suspensions. CryoText™ is processed from human tissue, donated following full term, c-section deliveries, in accordance with the FDA.
HOW IT IS APPLIED
This is a connective tissue supplement intended for homologous use only, as described in 21CFR 1271.10(a). Structural connective tissue that is missing or damaged severely may require new or additional tissue to create conditions that encourage the stability of anatomic infrastructure. CryoText™ does not use any material obtained from the embryo or fetus. CryoText™ has high concentrations of hyaluronic acid and growth factors and is processed from human tissue, donated following full term, c-section deliveries, in accordance with the FDA.
| PRODUCT | SKU | DOSE |
|---|
CryoText™ Pro75mg/mL Wharton’sjelly tissue product. |
CYP100-25 | 1 mL/75mg |
| CYP200-25 | 2 mL/150mg |
CryoText™ Plus50mg/mL Wharton’sjelly tissue product. |
CY+100-25 | 1 mL/50mg |
| CY+200-25 | 2 mL/100mg |
CryoText™35mg/mL Wharton’sjelly tissue product. |
CY100-25 | 1mL/35 mg |
| CY200-25 | 2mL/70 mg |
CryoText™ Booster25mg/mL Wharton’sjelly tissue product. |
CYB100-25 | 1mL/ 25 mg |
| CYB200-25 | 2mL/ 50 mg |
Supplementing A Structural Defect
A structural defect is defined as missing or damaged tissue in the body. Missing or damaged tissue often compromises the stability and structural integrity of its surrounding area.
CryoText™ is used as a replacement tissue that is intended to replace missing or damaged connective tissue. Wharton’s jelly is processed to preserve the structural integrity and original characteristics of the connective tissue relating to its utility to supplement missing or damaged tissue in the recipient. If you may be dealing with a structural defect, ask your physician if you could benefit from connective tissue supplementation.
Contact